Protein C-inhibitor (PCI) as a pharmaceutical and diagnostic agent, process for the preparation of such a pharmaceutical or diagnostic agent and a composition containing PCI
Abstract
Abstract Translated from German Es wird beschrieben, daß Protein C-Inhibitor als Pharmazeutikum, das heißt als Therapeutikum oder in vivo-Diagnostikum, sowie als in vitro-Diagnostikum geeignet ist sowie ein diesen Inhibitor enthaltendes Mittel. Es wird weiterhin ein Verfahren zur Herstellung eines solchen Pharmazeutikums oder Diagnostikums angegeben. Der Protein C-Inhibitor ist besonders zur Therapie und Diagnose von angiogenen Erkrankungen oder Tumoren geeignet. It is described that protein C inhibitor is suitable as a pharmaceutical, that is to say as a therapeutic or in vivo diagnostic, and as an in vitro diagnostic, and also an agent containing this inhibitor. A method for producing such a pharmaceutical or diagnostic agent is also specified. The protein C inhibitor is particularly suitable for the therapy and diagnosis of angiogenic diseases or tumors.
Inventors
- 👤 Thomas Dr. Stief
- 👤 Norbert Prof. Dr. Heimburger
- 👤 Klaus-Peter Dr. Radtke
Bibliographic Details
Claims Analysis
Total Claims: 0References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.